Clinical trial
A Phase II, Monocenter, Single Arm Study To Assess The Safety and Efficacy Of Combination Deoxycytidine and Deoxythymidine For Mitochondrial Depletion Disorders
NCT04802707 is registered in ClinicalTrials.gov with Kenneth Myers, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II, Monocenter, Single Arm Study To Assess The Safety and Efficacy Of Combination Deoxycytidine and Deoxythymidine For Mitochondrial Depletion Disorders
- Lead sponsor
- Kenneth Myers, MD
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- October 18, 2021
- Completion date
- December 30, 2029
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mitochondrial diseases, mitochondrial dna depletion, mitochondrial encephalomyopathy, mitochondrial encephalopathy, mitochondrial metabolism disorders